Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat tablets vs allopurinol in hyperuricemia (including gout)
CTR20132087Phase 2Active
- Sponsor
- Beijing Rundekang Medical Tech
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in hyperuricemia, gout, sponsored by Beijing Rundekang Medical Tech. Started Jan 2014; status: active.
02
Drugs
febuxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20132087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132087.